Anteris Plans Expansion of Global Heart Valve Clinical Trial

Anteris disclosed plans to broaden its heart valve trial worldwide. The expansion will involve additional clinical sites across multiple regions. The move aims to gather more data on the device’s safety and efficacy. Anteris hopes the larger trial will support regulatory submissions. The company sees the study as a step toward market approval. Participants will be monitored under the trial’s protocol. The announcement was reported by MassDevice. Further updates are expected as enrollment progresses.